Hi Leb. Correct me if I'm wrong but these 2021 warrants were the result of a private placement and as such were only open to high net worth individuals and not the average investor. As such, there would not be the urgency to scrape up funds to purchase the warrants by selling the overriding shares. Also since the shares were purchased for $8.50, such shares would incur a capital loss at the present share price. Not sure if selling at a loss would conflict with certain egoes.  Also I'm not sure if acquiring the warrants afterwards would trigger the 30 day rule.  It would seem to me that any sales of these roughly 1.8 million shares would be a perfect time for any interested funds to acquire thru negotiated cross trades.   Somewhat the same for the 2019 warrants.  Just my opinion based on possibly flawed reasoning.